Nucleoside reverse transcriptase inhibitor-sparing regimen (nonnucleoside reverse transcriptase inhibitor + protease inhibitor) was more likely associated with resistance comparing to nonnucleoside reverse transcriptase inhibitor or protease inhibitor + nucleoside reverse transcriptase inhibitor in
暂无分享,去创建一个
V. Calvez | C. Katlama | D. Costagliola | G. Peytavin | J. Molina | L. Assoumou | A. Marcelin | C. Soulié | J. Ghosn | C. Duvivier | Z. Ait-Arkoub